Références
[1] FMP company profile
FMP · api · 2026-09-29
https://financialmodelingprep.com/api/v3/profile/FFH.TO?symbol=FFH.TO
[2] Yahoo Finance quote for FFH.TO
Yahoo · api · 2026-09-29
https://finance.yahoo.com/quote/FFH.TO
[3] ANNUAL INFORMATION FORM
SEDAR+ · sedar · 2026-09-29 · Notice annuelle · Déposé le 2026-03-06 · Exercice 2025 · EN · pages 3-3; CORPORATE STRUCTURE
https://www.sedarplus.ca/csa-party/records/document.html?id=dc93fc9234f686ead10c239a0d297b2509d3587a82b4f0cec1f40121de5618e5
...New Jersey
Seneca Insurance Company, Inc. ............................... NewYork
Zenith National Insurance Corp. . ................................... Delaware
Zenith Insurance Company ...................................... California
Asian insurance subsidiaries
Falcon Insurance Company (Hong Kong) Limited ........................ Hong Kong
Fairfirst Insurance Limited . . ...................................... Sri Lanka
PT Asuransi Multi Artha Guna Tbk (80.87% owned) ...................... Indonesia
The Falcon Insurance Public Company Limited (99.83% owned) ............. Thailand
The P…
[4] ANNUAL INFORMATION FORM
SEDAR+ · sedar · 2026-09-29 · Notice annuelle · Déposé le 2026-03-06 · Exercice 2025 · EN · pages 5-5; DESCRIPTION OF THE BUSINESS
https://www.sedarplus.ca/csa-party/records/document.html?id=dc93fc9234f686ead10c239a0d297b2509d3587a82b4f0cec1f40121de5618e5
...in Ki Financial.
(c) The multiple voting shares of Fairfax India Holdings Corporation (“Fairfax India”) held by Fairfax represent 95.22% of the voting rights and
42.90% of the equity interest in Fairfax India.
(d) The multiple voting shares of Helios Fairfax Partners Corporation (“Helios Fairfax”) held by Fairfax represent 53.35% of the voting rights
and 34.45% of the equity interest in Helios Fairfax.
DESCRIPTION OF THE BUSINESS
Overview
Fairfax is a holding company which, through its subsidiaries, is primarily engaged in property and casualty
insurance and reinsurance and the assoc…
[5] Index to Management’s Discussion and Analysis of Financial Condition and Results of Operations
SEDAR+ · sedar · 2026-09-29 · Rapport de gestion annuel · Déposé le 2026-03-06 · Exercice 2025 · EN · pages 4-4; FAIRFAX FINANCIAL HOLDINGS LIMITED
https://www.sedarplus.ca/csa-party/records/document.html?id=f827075f2d2b737e6351d6cf583c7916f5c7a7e146a1913e2c26d142a28fc7ce
...combined ratio points), principally from the California wildfires, and increased
insurance acquisition expenses, partially offset by increased business volumes. The decrease in the insurance
service result of the Global Insurers and Reinsurers reporting segment was partially offset by an increase in
the International Insurers and Reinsurers reporting segment, primarily at Gulf Insurance and Fairfax Central
and Eastern Europe.
Underwriting Performance
• The company’s property and casualty insurance and reinsurance operations reported record underwriting
profit in 2025 of $1,816.6 (an…
[6] ANNUAL INFORMATION FORM
SEDAR+ · sedar · 2026-09-29 · Notice annuelle · Déposé le 2026-03-06 · Exercice 2025 · EN · pages 6-6; RISK FACTORS
https://www.sedarplus.ca/csa-party/records/document.html?id=dc93fc9234f686ead10c239a0d297b2509d3587a82b4f0cec1f40121de5618e5
FAIRFAX FINANCIAL HOLDINGS LIMITED
reputation, selling effort, perceived financial strength and the experience of the insurer or reinsurer in the line of
insurance or reinsurance to be written. We compete, and will continue to compete, with a large number of Canadian,
U.S. and foreign insurers and reinsurers, as well as certain underwriting syndicates, some of which have greater
financial, marketing and management resources than we do. In addition, some financial institutions, such as
banks, are now able to offer services similar to those offered by our reinsurance subsidiaries while in rece…
[7] Extracted web text
Web · web · 2026-09-29
https://www.insurancebusinessmag.com/ca/news/commercial-liability/scale-consolidation-and-control-how-canadas-pandc-market-is-tightening-at-the-top-555878.aspx
Scale, consolidation and control: how Canada’s P&C market is tightening at the top | Insurance Business CONTINUE TO SITE CONTINUE TO SITE SELECT REGION UNITED STATES CANADA UNITED KINGDOM AUSTRALIA NEW ZEALAND ASIA News Insurance News Industry News Columns Diversity & Inclusion Mergers & Acquisitions Legal Advisory Board Reinsurance TV Digital Transformation Risk Management Resources Annual Guides Business Strategy E-mag Editorial Panels Events Guides IB Talk Industry insights Insurance Companies Opinion Premium Content Webinars White papers Best In Insurance Specialty Cannabis Catastrophe & …
[8] Index to Management’s Discussion and Analysis of Financial Condition and Results of Operations
SEDAR+ · sedar · 2026-09-29 · Rapport de gestion annuel · Déposé le 2026-03-06 · Exercice 2025 · EN · pages 27-27; FAIRFAX FINANCIAL HOLDINGS LIMITED
https://www.sedarplus.ca/csa-party/records/document.html?id=f827075f2d2b737e6351d6cf583c7916f5c7a7e146a1913e2c26d142a28fc7ce
The discounted combined ratios, net insurance revenue and insurance service result for each operating company
in the Global Insurers and Reinsurers reporting segment for 2025 and 2024 are as set out in the table below:
Combined ratios, discounted Net insurance revenue Insurance service result
2025 2024 2025 2024 2025 2024
Allied World 80.1% 77.5% 5,273.1 5,156.3 1,050.9 1,159.3
Odyssey Group 86.0% 76.2% 5,321.5 5,050.3 745.5 1,203.1
Brit 81.9% 73.3% 2,469.6 2,106.7 446.2 563.4
Ki 77.3% 83.2% 751.3 665.2 170.8 111.6
Global Insurers and Reinsurers 82.5% 76.6% 13,815.5 12,978.5 2,413.4 3,037.…
[9] Extracted web text
Web · web · 2026-09-29
https://www.insurancebusinessmag.com/us/news/breaking-news/intact-beats-q1-street-forecasts-with-91-3-combined-ratio-574399.aspx
Intact beats Q1 street forecasts with 91.3% combined ratio | Insurance Business CONTINUE TO SITE CONTINUE TO SITE SELECT REGION UNITED STATES CANADA UNITED KINGDOM AUSTRALIA NEW ZEALAND ASIA News Insurance News Industry News Columns Diversity & Inclusion Mergers & Acquisitions Legal Advisory Board Reinsurance Risk Management TV Group Benefits Digital Transformation E&S Resources Annual Guides Business Strategy Data Hub E-mag Events Guides IB Talk Industry Reports Insurance Companies Leaders Network Risk, Compliance & Legal Opinion Premium Content Webinars White papers Best In Insurance Specia…
[10] FMP fmp_income_statement
FMP · api · 2026-09-29
https://financialmodelingprep.com/api/v3/income-statement/FFH.TO?period=annual&limit=10
[11] FMP fmp_key_metrics
FMP · api · 2026-09-29
https://financialmodelingprep.com/api/v3/key-metrics/FFH.TO?period=annual&limit=10
[12] Extracted web text
Web · web · 2026-09-29
https://www.fairfax.ca/press-releases/fairfax-financial-holdings-limited-financial-results-for-the-year-ended-december-31-2025-02-19-2026/
Fairfax Financial Holdings Limited: Financial Results for the Year Ended December 31, 2025 - Fairfax Financial Home About Fairfax Financial Investors Corporate Responsibility News Contact Employment Accessibility Standards Legal Notice Menu Menu All News Press Release Details Download PDF Fairfax Financial Holdings Limited: Financial Results for the Year Ended December 31, 2025 (Note: All dollar amounts in this news release are expressed in U.S. dollars except as otherwise noted. The financial results are derived from unaudited consolidated financial statements prepared using the recognition …
[13] Extracted web text
Web · web · 2026-09-29
https://insurance-portal.ca/article/market-shares-of-property-and-casualty-insurers-in-canada-in-2024/
[14] FMP fmp_income_statement
FMP · api · 2026-09-29
https://financialmodelingprep.com/api/v3/income-statement/IFC.TO?period=annual&limit=5
[15] FMP fmp_key_metrics
FMP · api · 2026-09-29
https://financialmodelingprep.com/api/v3/key-metrics/IFC.TO?period=annual&limit=5
[16] FMP fmp_income_statement
FMP · api · 2026-09-29
https://financialmodelingprep.com/api/v3/income-statement/FFH.TO?period=annual&limit=5
[17] Audited annual financial statements
SEDAR+ · sedar · 2026-09-29 · États financiers annuels audités · Déposé le 2026-03-06 · Exercice 2025 · EN · pages 25-25; note 21 and subsidiaries are presented in note 27.
https://www.sedarplus.ca/csa-party/records/document.html?id=45f132adb36a39a499bdb9535fbf8bf5c382be4ac1c56614820a2fb906e8bac6
...inputs that
require management to use its own assumptions. In particular, for private placement debt securities the company
uses industry accepted discounted cash flow models to value the instruments. Significant judgments and
assumptions are required to determine the discounted cash flows, including discount rates, long term growth rates
and credit spreads, as applicable. See note 5 for details of the company’s Level 3 financial instruments and the
valuation assumptions applied.
Impairment assessments of goodwill and indefinite-lived intangible assets
Goodwill and indefinite-lived intang…
[18] Audited annual financial statements
SEDAR+ · sedar · 2026-09-29 · États financiers annuels audités · Déposé le 2026-03-06 · Exercice 2025 · EN · pages 10-10; FAIRFAX FINANCIAL HOLDINGS LIMITED
https://www.sedarplus.ca/csa-party/records/document.html?id=45f132adb36a39a499bdb9535fbf8bf5c382be4ac1c56614820a2fb906e8bac6
Consolidated Statements of Cash Flows
for the years ended December 31, 2025 and 2024
(US$ millions)
Notes 2025 2024
Operating activities
Net earnings 5,283.8 4,262.9
Depreciation, amortization and impairment charges 783.8 753.8
Net bond discount amortization (258.5) (310.2)
Amortization of share-based payment awards 16 176.6 164.9
Share of profit of associates 6 (816.1) (956.3)
Deferred income taxes 18 201.9 255.0
Net gains on investments 5 (3,151.4) (1,067.2)
Net purchases of investments classified at FVTPL 25 (4,059.1) (515.8)
Changes in operating assets and liabilities 25 4,258.…
[19] Audited annual financial statements
SEDAR+ · sedar · 2026-09-29 · États financiers annuels audités · Déposé le 2026-03-06 · Exercice 2025 · EN · pages 5-5; FAIRFAX FINANCIAL HOLDINGS LIMITED
https://www.sedarplus.ca/csa-party/records/document.html?id=45f132adb36a39a499bdb9535fbf8bf5c382be4ac1c56614820a2fb906e8bac6
FAIRFAX FINANCIAL HOLDINGS LIMITED
Consolidated Financial Statements
Consolidated Balance Sheets
as at December 31, 2025 and December 31, 2024
(US$ millions)
December 31, December 31,
Notes 2025 2024
Assets
Holding company cash and investments (including assets pledged for
derivative obligations – $207.8; December 31, 2024 – $193.6) 5, 25 2,724.9 2,502.7
Insurance contract receivables 11 1,006.2 780.4
Portfolio investments
Subsidiary cash and short term investments (including restricted cashand cash equivalents – $640.4; December 31, 2024 – $1,240.7) 5, 25 8,979.2 7,620.5
Bonds (cost…
[20] Index to Management’s Discussion and Analysis of Financial Condition and Results of Operations
SEDAR+ · sedar · 2026-09-29 · Rapport de gestion annuel · Déposé le 2026-03-06 · Exercice 2025 · EN · pages 24-24; FAIRFAX FINANCIAL HOLDINGS LIMITED
https://www.sedarplus.ca/csa-party/records/document.html?id=f827075f2d2b737e6351d6cf583c7916f5c7a7e146a1913e2c26d142a28fc7ce
...this MD&A.
North American Insurers
2025 2024
Combined ratio, discounted 85.5% 85.3%
Combined ratio, undiscounted:
Loss & LAE – accident year 63.7% 63.1%
Commissions 15.7% 15.5%
Underwriting expenses 16.2% 16.5%
Combined ratio, undiscounted – accident year 95.6% 95.1%
Net favourable prior year reserve development (1.8)% (1.4)%
Combined ratio, undiscounted – calendar year 93.8% 93.7%
Gross premiums written 9,334.6 8,866.9
Net premiums written 7,638.5 7,201.6
Net insurance revenue(1) 7,807.5 7,482.0
Insurance service result 1,128.9 1,101.1
Other insurance operating expenses (322.6…
[21] Index to Management’s Discussion and Analysis of Financial Condition and Results of Operations
SEDAR+ · sedar · 2026-09-29 · Rapport de gestion annuel · Déposé le 2026-03-06 · Exercice 2025 · EN · pages 85-85; note 22 (Financial Risk Management, under the heading “Market Risk”) to the consolidated financial statements for
https://www.sedarplus.ca/csa-party/records/document.html?id=f827075f2d2b737e6351d6cf583c7916f5c7a7e146a1913e2c26d142a28fc7ce
Glossary of Non-GAAP and Other Financial Measures
Management analyzes and assesses the underlying insurance and reinsurance companies, and the financial position
of the consolidated company, through various measures and ratios. Certain of those measures and ratios, which
have been used consistently and disclosed regularly in the company’s Annual Reports and interim financial
reporting, do not have a prescribed meaning under IFRS Accounting Standards and may not be comparable to
similar measures presented by other companies.
Supplementary Financial Measures
Net insurance revenue – This meas…
[22] NOTICE OF ANNUAL MEETING OF SHAREHOLDERS
SEDAR+ · sedar · 2026-09-29 · Circulaire de sollicitation de procurations par la direction · Déposé le 2026-03-06 · Exercice 2025 · EN · pages 34-34; SHAREHOLDER PROPOSAL
https://www.sedarplus.ca/csa-party/records/document.html?id=3475f51eeac7849b645c17edc828c8b23d2d9328d8b97c76681969548bf72121
SCHEDULE A
SHAREHOLDER PROPOSAL
Investors for Paris Compliance, 185-911 Yates St. Suite 561, Victoria, British Columbia V8V 4Y9, has submitted the following
shareholder proposal on behalf of The Salal Foundation for consideration at the Meeting. Fairfax is required by applicable
law to attach the shareholder proposal, and the related supporting statement, to the Circular. The proposal and the
supporting statement represent the view of the shareholder submitting it. Fairfax has, and assumes, no responsibility for
the content of such proposal and related supporting statement, including the op…
[23] NOTICE OF ANNUAL MEETING OF SHAREHOLDERS
SEDAR+ · sedar · 2026-09-29 · Circulaire de sollicitation de procurations par la direction · Déposé le 2026-03-06 · Exercice 2025 · EN · pages 35-35; SHAREHOLDER PROPOSAL
https://www.sedarplus.ca/csa-party/records/document.html?id=3475f51eeac7849b645c17edc828c8b23d2d9328d8b97c76681969548bf72121
...by year-end 2030, and reach 50% of
AUM in impact or climate transition investments by year-end 2026, and 60% by 2030.17
Long-term value creation in the insurance industry is highly dependent on managing climate risk. Fairfax can begin to do
this by responding favourably to this proposal.
Board and Management Statement
After serious consideration of the above proposal (the “Proposal”) by management, which included discussions with
Fairfax’s insurance and reinsurance operations, as well as our non-insurance businesses, which would have familiarity
with the subject matter of the Proposal, a…
[24] NOTICE OF ANNUAL MEETING OF SHAREHOLDERS
SEDAR+ · sedar · 2026-09-29 · Circulaire de sollicitation de procurations par la direction · Déposé le 2026-03-06 · Exercice 2025 · EN · pages 27-27; S&P P&C* (US$) 142100 21311 9157234
https://www.sedarplus.ca/csa-party/records/document.html?id=3475f51eeac7849b645c17edc828c8b23d2d9328d8b97c76681969548bf72121
...accordingly has, in conjunction with the Audit Committee,
established a Whistleblower Policy pursuant to which violations of the Code can be reported confidentially or anonymously
and without risk of recrimination. The Board has also approved a Public Disclosure Policy applicable to all directors and
employees and those authorized to speak on our behalf.
Among other things, the Code requires every director, officer and employee of Fairfax to be scrupulous in seeking to
avoid any actual, potential or perceived conflict of interest and to constantly consider whether any may exist. If any
ma…
[25] Python calc
Calcul · calculation · 2026-09-29
calculation://calc_python
Calcul : rev_2016=9275400000
rev_2025=30405400000
cagr=(rev_2025/rev_2016)**(1/9)-1
cagr — {"code": "rev_2016=9275400000\nrev_2025=30405400000\ncagr=(rev_2025/rev_2016)**(1/9)-1\ncagr"}
[26] FMP fmp_ratios
FMP · api · 2026-09-29
https://financialmodelingprep.com/api/v3/ratios/FFH.TO?period=annual&limit=10
[27] FMP fmp_cash_flow_statement
FMP · api · 2026-09-29
https://financialmodelingprep.com/api/v3/cash-flow-statement/FFH.TO?period=annual&limit=10
[28] FMP fmp_balance_sheet
FMP · api · 2026-09-29
https://financialmodelingprep.com/api/v3/balance-sheet-statement/FFH.TO?period=annual&limit=10
[29] NOTICE OF ANNUAL MEETING OF SHAREHOLDERS
SEDAR+ · sedar · 2026-09-29 · Circulaire de sollicitation de procurations par la direction · Déposé le 2026-03-06 · Exercice 2025 · EN · pages 20-20; V. PREM WATSA
https://www.sedarplus.ca/csa-party/records/document.html?id=3475f51eeac7849b645c17edc828c8b23d2d9328d8b97c76681969548bf72121
...that are designed to hedge or offset any decrease in
market value of our equity securities granted as compensation or otherwise held by the individual. The benefit of these
awards over time will derive from long-term value creation rather than from short-term gains.
The Board has considered Fairfax’s particular circumstances and the reasonably unique elements of our officer
compensation (including, without limitation, the low compensation requested by our CEO (a fixed, restrained annual
salary, no annual bonus and no equity or other incentives), the reasonably small aggregate amount of exe…
[30] NOTICE OF ANNUAL MEETING OF SHAREHOLDERS
SEDAR+ · sedar · 2026-09-29 · Circulaire de sollicitation de procurations par la direction · Déposé le 2026-03-06 · Exercice 2025 · EN · pages 19-19; V. PREM WATSA
https://www.sedarplus.ca/csa-party/records/document.html?id=3475f51eeac7849b645c17edc828c8b23d2d9328d8b97c76681969548bf72121
Executive Share Ownership
All of our executive officers are long term shareholders of Fairfax. While we do not have formal executive share ownership
guidelines, our executive officers are expected to hold their shares throughout their tenure. In practice, with the exception
of charitable donations and the repurchase for cancellation of subordinate voting shares owned by V. Prem Watsa in 2024,
there has been almost no trading of our shares by our executive officers.
Compensation Discussion and Analysis
Our Compensation Committee, in consultation with our CEO, is responsible for establishing o…
[31] NOTICE OF ANNUAL MEETING OF SHAREHOLDERS
SEDAR+ · sedar · 2026-09-29 · Circulaire de sollicitation de procurations par la direction · Déposé le 2026-03-06 · Exercice 2025 · EN · pages 25-25; S&P P&C* (US$) 142100 21311 9157234
https://www.sedarplus.ca/csa-party/records/document.html?id=3475f51eeac7849b645c17edc828c8b23d2d9328d8b97c76681969548bf72121
Compensation Committee
The members of our Compensation Committee are Robert Gunn (Chair), David Johnston and Timothy Price, all of whom
are independent and have the necessary skills and experience to enable them to make decisions on the suitability of our
compensation policies and practices. Mr. Gunn is a former executive officer of Royal & SunAlliance plc, where he served
as Chief Executive Officer and in several other senior management positions involving direct responsibility for executive
compensation matters. Mr. Gunn also has past experience in executive compensation as a member of the …
[32] FORM 52-109F2
SEDAR+ · sedar · 2026-09-29 · Attestation intermédiaire - Chef de la direction (52-109F2) · Déposé le 2026-04-30 · Exercice 2025 · EN · pages 1-1; 5.3 Limitation on scope of design: N/A
https://www.sedarplus.ca/csa-party/records/document.html?id=2c087d06b22a92aa9111ca9b1ce1d8fc36b937e31ee5cffb3f2c766e7f228841
...the interim
financial report together with the other financial information included in the interim filings fairly
present in all material respects the financial condition, financial performance and cash flows of
the issuer, as of the date of and for th e periods presented in the interim filings.
4. Responsibility: The issuer’s other certifying officer(s) and I are responsible for establishing and
maintaining disclosure controls and procedures (DC&P) and internal control over financial
reporting (ICFR), as those terms are defined in National Instrument 52-109 Certification of
Disclos…
[33] FMP fmp_key_metrics
FMP · api · 2026-09-29
https://financialmodelingprep.com/api/v3/key-metrics/FFH.TO?period=annual&limit=5
[34] Index to Management’s Discussion and Analysis of Financial Condition and Results of Operations
SEDAR+ · sedar · 2026-09-29 · Rapport de gestion annuel · Déposé le 2026-03-06 · Exercice 2025 · EN · pages 51-51; EXCO 11.2 17.5 4.8 33.5 2.2 – 3.9 39.6
https://www.sedarplus.ca/csa-party/records/document.html?id=f827075f2d2b737e6351d6cf583c7916f5c7a7e146a1913e2c26d142a28fc7ce
...(210.2) 296.8
Bonds and preferred stocks – convertible 100.2 78.5 178.7 18.2 (3.6) 14.6
Other equity derivatives(2)(3) 210.1 838.4 1,048.5 375.3 564.0 939.3
Disposition of non-insurance associates(4)(5)(6)(7) 233.8 – 233.8 575.5 – 575.5
Other 97.9 – 97.9 32.8 – 32.8
Long equity exposures and financial effects 1,033.3 2,016.8 3,050.1 1,508.8 350.2 1,859.0
Bonds (190.6) 573.8 383.2 (16.5) (590.8) (607.3)
U.S. treasury bond forward contracts (42.7) 44.9 2.2 (90.0) (34.0) (124.0)
Total bonds (233.3) 618.7 385.4 (106.5) (624.8) (731.3)
Foreign currency(8) (377.3) (62.4) (439.7) 166.6 (1…
[35] Python calc
Calcul · calculation · 2026-09-29
calculation://calc_python
Calcul : start=27456850
end=21450000
pct_change = (end-start)/start*100
cagr = ((end/start)**(1/4)-1)*100
{"pct_change": pct_change, "cagr": cagr} — {"code": "start=27456850\nend=21450000\npct_change = (end-start)/start*100\ncagr = ((end/start)**(1/4)-1)*100\n{\"pct_change\": pct_change, \"cagr\": cagr}"}
[36] Index to Management’s Discussion and Analysis of Financial Condition and Results of Operations
SEDAR+ · sedar · 2026-09-29 · Rapport de gestion annuel · Déposé le 2026-03-06 · Exercice 2025 · EN · pages 83-83; FAIRFAX FINANCIAL HOLDINGS LIMITED
https://www.sedarplus.ca/csa-party/records/document.html?id=f827075f2d2b737e6351d6cf583c7916f5c7a7e146a1913e2c26d142a28fc7ce
...for all of its committees, approved a Code of Business Conduct
and Ethics, an Anti-Corruption Policy and a Modern Slavery Policy, which are applicable to all directors, officers
and employees of the company. The Board of Directors also established, in conjunction with the Audit Committee,
a Whistleblower Policy. The company continues to monitor developments in the area of corporate governance as
well as its own procedures.
Forward-Looking Statements
Certain statements contained herein may constitute forward-looking statements and are made pursuant to the “safe
harbour” provisions of the…
[37] Index to Management’s Discussion and Analysis of Financial Condition and Results of Operations
SEDAR+ · sedar · 2026-09-29 · Rapport de gestion annuel · Déposé le 2026-03-06 · Exercice 2025 · EN · pages 84-84; FAIRFAX FINANCIAL HOLDINGS LIMITED
https://www.sedarplus.ca/csa-party/records/document.html?id=f827075f2d2b737e6351d6cf583c7916f5c7a7e146a1913e2c26d142a28fc7ce
...with legal or
regulatory proceedings or significant litigation; failures or security breaches of our computer and data processing
systems; the influence exercisable by our significant shareholder; adverse fluctuations in foreign currency exchange
rates; our dependence on independent brokers over whom we exercise little control; financial reporting risks
relating to deferred taxes associated with amendments to IAS 12; impairment of the carrying value of our goodwill,
indefinite-lived intangible assets or investments in associates; our failure to realize deferred income tax assets;
risks ass…
[38] FORM 52-109F2
SEDAR+ · sedar · 2026-09-29 · Attestation intermédiaire - Chef des finances (52-109F2) · Déposé le 2026-04-30 · Exercice 2025 · EN · pages 1-1; 5.3 Limitation on scope of design: N/A
https://www.sedarplus.ca/csa-party/records/document.html?id=e305d874455c7eaaa7e6e644c03f110a6c266a4bd3566c2e029e92001688a42e
FORM 52-109F2
CERTIFICATION OF INTERIM FILINGS
FULL CERTIFICATE
I, Amy Sherk, Vice President and Chief Financial Offi cer of Fairfax Financial Holdings Limited, certify
the following:
1. Review: I have reviewed the interim financial report and interim MD&A (together, the “interim
filings”) of Fairfax Financial Holdings Limited (the “issuer”) for the interim period ended March
31, 2026.
2. No misrepresentations: Based on my knowledge, having exercised reasonable diligence, the
interim filings do not contain any untrue statement of a material fact or omit to state a material
fact requi…
[39] FMP fmp_income_statement
FMP · api · 2026-09-29
https://financialmodelingprep.com/api/v3/income-statement/FFH.TO?period=annual&limit=6
[40] FMP fmp_cash_flow_statement
FMP · api · 2026-09-29
https://financialmodelingprep.com/api/v3/cash-flow-statement/FFH.TO?period=annual&limit=6
[41] FMP fmp_ttm income statement
FMP · api · 2026-09-29
https://financialmodelingprep.com/api/v3/income-statement/FFH.TO?period=quarter&limit=4
[42] FMP fmp_ttm cash flow statement
FMP · api · 2026-09-29
https://financialmodelingprep.com/api/v3/cash-flow-statement/FFH.TO?period=quarter&limit=4
[43] Run DCF once per scenario and compare the outputs
Bull Run Valuation · calculation · 2026-09-29
valuation://valuation_scenario_compare
Calcul : Run DCF once per scenario and compare the outputs — {"period": "As of 2025-12-31", "scenarios": [{"discount_rate": 0.16, "discount_rate_justification": "Raised above the 15% hurdle because Fairfax operates in a cyclical, competitive P&C/reinsurance market with low demonstrated structural moat and earnings quality is influenced by reserve releases and investment-market marks; a higher required return compensates for underwriting/catastrophe and valuation-model risk.", "historical_years": [{"calendar_year": "2023", "fcf_margin": -0.021450845804591976, "revenue": 25803100000, "shares_outstanding": 25006116}, {"calendar_year": "2024", "fcf_margin": 0.1260400239076336, "revenue": 28445500000, "shares_outstanding": 22373092}, {"calendar_year": "2025", "fcf_margin": 0.0788207478973387, "revenue": 30405400000, "shares_outstanding": 21450000}], "name": "Prudent", "net_debt": 3151100000, "net_debt_justification": "Uses FY2025 net debt from balance sheet (total debt minus cash) as the shared capital structure anchor.", "projected_years": [{"calendar_year": "2026", "fcf_margin": 0.03, "fcf_margin_justification": "Anchored to the much lower 2026-Q2 TTM FCF margin (~2.8%) vs FY2025 (~7.9%), reflecting insurer cash-flow volatility and assuming limited favorable working-capital timing benefits.", "revenue": 33400000000, "revenue_justification": "TTM is already ~US$32.7B; this year assumes only a modest step-up from written premium growth and investment income, consistent with insurance cycle normalization and no reliance on large realized gains.", "shares_outstanding": 22160000, "shares_outstanding_justification": "Flat vs TTM share count; assumes buybacks roughly offset by modest issuance/employee programs in a year of volatile cash generation."}, {"calendar_year": "2027", "fcf_margin": 0.035, "fcf_margin_justification": "Slight normalization as underwriting profits remain positive, but still well below FY2024–FY2025 due to conservative treatment of float/investment cash flows.", "revenue": 34400000000, "revenue_justification": "~3% growth assumes rate increases and exposure growth roughly offset by competitive pricing pressure in a softening market.", "shares_outstanding": 22100000, "shares_outstanding_justification": "~0.3% net reduction assuming modest opportunistic repurchases resume as cash generation stabilizes."}, {"calendar_year": "2028", "fcf_margin": 0.04, "fcf_margin_justification": "Gradual improvement as capex stays modest and underwriting discipline persists, but acknowledging that calendar-year results can be flattered by reserve releases (not assumed to repeat).", "revenue": 35400000000, "revenue_justification": "~3% growth continues, driven by inflation-linked premium base but tempered by competitive conditions and catastrophe volatility.", "shares_outstanding": 22000000, "shares_outstanding_justification": "~0.5% buyback rate assuming continued capital return policy but at a slower pace than 2021–2025."}, {"calendar_year": "2029", "fcf_margin": 0.042, "fcf_margin_justification": "Small improvement from operating leverage and stable catastrophe experience on average, while keeping a buffer for adverse reserve development years.", "revenue": 36500000000, "revenue_justification": "~3% growth reflects mature insurer profile: premiums/investment income grow around nominal GDP-like pace.", "shares_outstanding": 21900000, "shares_outstanding_justification": "~0.5% annual share count decline as buybacks continue but remain secondary to maintaining strong liquidity."}, {"calendar_year": "2030", "fcf_margin": 0.045, "fcf_margin_justification": "Approaches a through-the-cycle mid-single-digit FCF margin as underwriting and investment income remain profitable but less favorable than 2024–2025 peak conditions.", "revenue": 37600000000, "revenue_justification": "~3% growth assumes no major acquisitions and a normal competitive environment.", "shares_outstanding": 21800000, "shares_outstanding_justification": "~0.5% reduction reflecting continued but moderate repurchases."}, {"calendar_year": "2031", "fcf_margin": 0.045, "fcf_margin_justification": "Held flat to reflect that cash conversion for insurers is structurally volatile and unlikely to expand steadily every year.", "revenue": 38700000000, "revenue_justification": "~3% growth continues; assumes Fairfax compounds float but without outsized market share gains (low-moat competitive market).", "shares_outstanding": 21700000, "shares_outstanding_justification": "~0.5% reduction as long as shares are repurchased when management views them below intrinsic value."}, {"calendar_year": "2032", "fcf_margin": 0.045, "fcf_margin_justification": "Flat mid-4% FCF margin represents a conservative through-cycle cash generation level below FY2025's reported ~8% margin.", "revenue": 39900000000, "revenue_justification": "~3% growth assumes stable premium volume and reinvestment income; no assumption of unusually strong investment gains.", "shares_outstanding": 21600000, "shares_outstanding_justification": "~0.5% reduction from ongoing buybacks."}, {"calendar_year": "2033", "fcf_margin": 0.045, "fcf_margin_justification": "Flat to reflect competitive pressure and catastrophe volatility offsetting efficiency improvements.", "revenue": 41100000000, "revenue_justification": "~3% growth persists with inflation-linked premiums; acknowledges reinsurance pricing cycles can weaken.", "shares_outstanding": 21500000, "shares_outstanding_justification": "~0.5% reduction, consistent with shareholder-return orientation but not heroic."}, {"calendar_year": "2034", "fcf_margin": 0.045, "fcf_margin_justification": "Maintained at 4.5% as a steady-state cash generation estimate absent reserve-release tailwinds.", "revenue": 42300000000, "revenue_justification": "~3% growth assumes Fairfax remains a diversified P&C and reinsurance group without major transformative acquisitions.", "shares_outstanding": 21400000, "shares_outstanding_justification": "~0.5% reduction."}, {"calendar_year": "2035", "fcf_margin": 0.045, "fcf_margin_justification": "Terminal-year FCF margin held steady to avoid embedding an assumption of structurally improving insurance profitability in a low-moat market.", "revenue": 43600000000, "revenue_justification": "~3% growth into terminal period aligns with long-run nominal growth expectations for a mature insurer.", "shares_outstanding": 21300000, "shares_outstanding_justification": "~0.5% reduction, reflecting a continuing but moderate buyback program."}], "terminal_growth_rate": 0.02, "terminal_growth_rate_justification": "Long-run cash flow growth capped near 2% (below nominal GDP) because P&C insurance is competitive/cyclical and long-term real growth is limited; assumes Fairfax can compound but not indefinitely outgrow the economy.", "ttm": {"calendar_year": "2026-Q2", "fcf_margin": 0.02843602770061797, "revenue": 32736342741, "shares_outstanding": 22162793}}, {"discount_rate": 0.15, "discount_rate_justification": "Uses the investor’s 15% minimum required return. Despite low structural moat and some earnings-quality volatility, Fairfax’s conservative leverage, strong recent underwriting and shareholder-friendly buybacks keep risk from demanding a materially higher hurdle in the base case.", "historical_years": [{"calendar_year": "2023", "fcf_margin": -0.021450845804591976, "revenue": 25803100000, "shares_outstanding": 25006116}, {"calendar_year": "2024", "fcf_margin": 0.1260400239076336, "revenue": 28445500000, "shares_outstanding": 22373092}, {"calendar_year": "2025", "fcf_margin": 0.0788207478973387, "revenue": 30405400000, "shares_outstanding": 21450000}], "name": "Réaliste", "net_debt": 3151100000, "net_debt_justification": "Uses FY2025 net debt from balance sheet (total debt minus cash) as the shared capital structure anchor.", "projected_years": [{"calendar_year": "2026", "fcf_margin": 0.04, "fcf_margin_justification": "Assumes partial normalization from the low TTM FCF margin (~2.8%) as working-capital swings mean-revert, but still below FY2025’s ~7.9% to avoid extrapolating peak conditions.", "revenue": 34000000000, "revenue_justification": "Reflects the run-rate implied by the 2026-Q2 TTM (~US$32.7B) plus modest organic premium growth and higher reinvestment yields, consistent with recent revenue expansion but allowing for cyclicality.", "shares_outstanding": 22050000, "shares_outstanding_justification": "~0.5% reduction vs TTM, reflecting continued buybacks but slowed from 2021–2025’s pace as valuation rises and management preserves flexibility."}, {"calendar_year": "2027", "fcf_margin": 0.05, "fcf_margin_justification": "Improves as underwriting profit stays positive and capex remains modest, with fewer adverse cash timing effects than in the TTM period.", "revenue": 36000000000, "revenue_justification": "~6% growth driven by continued premium compounding and investment income; assumes underwriting remains disciplined but market begins to normalize.", "shares_outstanding": 21900000, "shares_outstanding_justification": "~0.7% net reduction assuming steady repurchases funded by retained earnings and moderate dividends."}, {"calendar_year": "2028", "fcf_margin": 0.055, "fcf_margin_justification": "Moves toward mid-single-digit through-cycle cash generation, acknowledging that FY2024’s ~12.6% FCF margin was unusually strong.", "revenue": 38000000000, "revenue_justification": "~6% growth assumes Fairfax maintains underwriting profitability across platforms while benefiting from inflation-driven premium base.", "shares_outstanding": 21750000, "shares_outstanding_justification": "~0.7% reduction reflecting ongoing buybacks and low dilution."}, {"calendar_year": "2029", "fcf_margin": 0.055, "fcf_margin_justification": "Held steady as competitive pressures and catastrophe years offset efficiency gains; does not assume continuing reserve-release tailwinds.", "revenue": 40000000000, "revenue_justification": "~5% growth reflects gradual deceleration as the business scales; no major acquisition-driven step-change assumed.", "shares_outstanding": 21600000, "shares_outstanding_justification": "~0.7% reduction from buybacks."}, {"calendar_year": "2030", "fcf_margin": 0.057, "fcf_margin_justification": "Slight improvement from operating leverage and portfolio yield, while keeping conservatism due to investment-market cyclicality.", "revenue": 42000000000, "revenue_justification": "~5% growth assumes premiums and investment income keep compounding modestly above inflation, supported by disciplined underwriting.", "shares_outstanding": 21450000, "shares_outstanding_justification": "~0.7% reduction continuing the repurchase program."}, {"calendar_year": "2031", "fcf_margin": 0.057, "fcf_margin_justification": "Flat as steady-state assumption; recognizes that P&C underwriting profitability is not structurally expanding in a low-moat market.", "revenue": 44100000000, "revenue_justification": "~5% growth continues with exposure growth and pricing roughly in line with nominal economic growth.", "shares_outstanding": 21300000, "shares_outstanding_justification": "~0.7% reduction as long as capital returns remain a priority."}, {"calendar_year": "2032", "fcf_margin": 0.057, "fcf_margin_justification": "Flat, reflecting a stable through-cycle FCF margin slightly above the prudent case but below peak years.", "revenue": 46300000000, "revenue_justification": "~5% growth assumes sustained underwriting discipline and continued reinvestment income; no extraordinary realized gains required.", "shares_outstanding": 21150000, "shares_outstanding_justification": "~0.7% reduction from buybacks."}, {"calendar_year": "2033", "fcf_margin": 0.057, "fcf_margin_justification": "Flat to avoid embedding structural margin expansion unsupported by a strong moat.", "revenue": 48600000000, "revenue_justification": "~5% growth; assumes Fairfax maintains its diversified global platform and grows with the market.", "shares_outstanding": 21000000, "shares_outstanding_justification": "~0.7% reduction."}, {"calendar_year": "2034", "fcf_margin": 0.057, "fcf_margin_justification": "Flat stable margin, recognizing reserve releases are a judgment-driven tailwind that may not persist.", "revenue": 51000000000, "revenue_justification": "~5% growth as the company compounds book value and float; assumes no large dilution events.", "shares_outstanding": 20850000, "shares_outstanding_justification": "~0.7% reduction reflecting continued share count discipline."}, {"calendar_year": "2035", "fcf_margin": 0.057, "fcf_margin_justification": "Terminal-year margin held at ~5.7% as an earnings-power estimate under normalized conditions, well below the best historical year and above the low TTM trough.", "revenue": 53600000000, "revenue_justification": "~5% growth into the terminal period assumes Fairfax grows slightly faster than long-run inflation due to global mix and reinvestment, but not at venture-like rates.", "shares_outstanding": 20700000, "shares_outstanding_justification": "~0.7% reduction consistent with ongoing buybacks, but slower than 2021–2025’s aggressive pace."}], "terminal_growth_rate": 0.02, "terminal_growth_rate_justification": "Long-run growth set at 2% because insurance is a competitive, cyclical industry and long-term growth should not exceed nominal GDP for extended periods; assumes Fairfax can retain and reinvest earnings but not generate perpetual above-economy growth.", "ttm": {"calendar_year": "2026-Q2", "fcf_margin": 0.02843602770061797, "revenue": 32736342741, "shares_outstanding": 22162793}}, {"discount_rate": 0.15, "discount_rate_justification": "Keeps the 15% investor hurdle even in the optimistic case because catastrophe and capital-market risks remain inherent; upside comes from cash-flow strength rather than a lower required return.", "historical_years": [{"calendar_year": "2023", "fcf_margin": -0.021450845804591976, "revenue": 25803100000, "shares_outstanding": 25006116}, {"calendar_year": "2024", "fcf_margin": 0.1260400239076336, "revenue": 28445500000, "shares_outstanding": 22373092}, {"calendar_year": "2025", "fcf_margin": 0.0788207478973387, "revenue": 30405400000, "shares_outstanding": 21450000}], "name": "Optimiste", "net_debt": 3151100000, "net_debt_justification": "Uses FY2025 net debt from balance sheet (total debt minus cash) as the shared capital structure anchor.", "projected_years": [{"calendar_year": "2026", "fcf_margin": 0.05, "fcf_margin_justification": "Assumes cash generation rebounds faster from the low TTM level as underwriting profit remains strong and working-capital timing normalizes.", "revenue": 34500000000, "revenue_justification": "Assumes strong but plausible continuation of premium growth and investment income with the TTM run-rate as baseline, helped by still-firm market pricing.", "shares_outstanding": 21950000, "shares_outstanding_justification": "~1% reduction vs TTM reflecting management’s demonstrated willingness to repurchase shares aggressively when attractive."}, {"calendar_year": "2027", "fcf_margin": 0.065, "fcf_margin_justification": "Moves toward FY2025-like cash generation as investment income stays high and catastrophe losses are average rather than elevated.", "revenue": 37200000000, "revenue_justification": "~8% growth assumes underwriting conditions remain relatively favorable and Fairfax continues compounding float across platforms.", "shares_outstanding": 21700000, "shares_outstanding_justification": "~1.1% reduction as buybacks continue at a healthy pace supported by retained earnings."}, {"calendar_year": "2028", "fcf_margin": 0.07, "fcf_margin_justification": "Assumes underwriting and investment results stay strong and reserve development remains favorable on balance, lifting FCF margin above a through-cycle average.", "revenue": 40200000000, "revenue_justification": "~8% growth assumes continued hard-market-like conditions longer than expected plus selective bolt-on acquisitions.", "shares_outstanding": 21450000, "shares_outstanding_justification": "~1.2% reduction as buybacks remain meaningful and dilution stays low."}, {"calendar_year": "2029", "fcf_margin": 0.07, "fcf_margin_justification": "Held flat at 7% to reflect sustained strong underwriting, but not assuming continued expansion every year.", "revenue": 43400000000, "revenue_justification": "~8% growth continues, reflecting strong pricing, exposure growth, and higher reinvestment yields on the portfolio.", "shares_outstanding": 21200000, "shares_outstanding_justification": "~1.2% reduction driven by continued repurchases."}, {"calendar_year": "2030", "fcf_margin": 0.07, "fcf_margin_justification": "Maintained at 7% as Fairfax sustains strong profitability across underwriting platforms.", "revenue": 46500000000, "revenue_justification": "~7% growth as conditions begin to normalize but Fairfax still compounds above the market due to underwriting execution.", "shares_outstanding": 20950000, "shares_outstanding_justification": "~1.2% reduction from ongoing buybacks."}, {"calendar_year": "2031", "fcf_margin": 0.07, "fcf_margin_justification": "Flat 7% assumes continued favorable underwriting and stable catastrophe experience over time.", "revenue": 49800000000, "revenue_justification": "~7% growth assumes steady premium growth and investment income; no major adverse cycle assumed.", "shares_outstanding": 20700000, "shares_outstanding_justification": "~1.2% reduction."}, {"calendar_year": "2032", "fcf_margin": 0.07, "fcf_margin_justification": "Held flat; optimistic case assumes Fairfax can maintain near-FY2025 cash generation levels for an extended period.", "revenue": 53200000000, "revenue_justification": "~7% growth continues as Fairfax expands globally and compounds float, aided by disciplined underwriting culture.", "shares_outstanding": 20450000, "shares_outstanding_justification": "~1.2% reduction from buybacks."}, {"calendar_year": "2033", "fcf_margin": 0.07, "fcf_margin_justification": "Flat at 7% to avoid assuming indefinite margin expansion beyond already-strong levels.", "revenue": 56900000000, "revenue_justification": "~7% growth; assumes Fairfax’s mix shift toward specialty lines and reinsurance supports sustained premium growth.", "shares_outstanding": 20200000, "shares_outstanding_justification": "~1.2% reduction."}, {"calendar_year": "2034", "fcf_margin": 0.07, "fcf_margin_justification": "Sustained strong underwriting and investment income keep cash generation elevated.", "revenue": 60900000000, "revenue_justification": "~7% growth; assumes continued compounding but with no transformational acquisitions that would add integration risk.", "shares_outstanding": 19950000, "shares_outstanding_justification": "~1.2% reduction from an ongoing buyback program."}, {"calendar_year": "2035", "fcf_margin": 0.07, "fcf_margin_justification": "Terminal-year margin held at 7% reflecting a view that Fairfax’s underwriting execution advantage persists, though industry remains competitive.", "revenue": 65200000000, "revenue_justification": "~7% growth into terminal period assumes Fairfax remains a disciplined compounder of book value and float, sustaining above-industry growth longer than typical.", "shares_outstanding": 19700000, "shares_outstanding_justification": "~1.3% reduction continuing aggressive repurchases."}], "terminal_growth_rate": 0.025, "terminal_growth_rate_justification": "Assumes Fairfax can outgrow inflation modestly in perpetuity (2.5%) by compounding float and reinvesting at attractive rates, while still staying within a reasonable band near long-run nominal GDP.", "ttm": {"calendar_year": "2026-Q2", "fcf_margin": 0.02843602770061797, "revenue": 32736342741, "shares_outstanding": 22162793}}]}
[44] FMP fmp_balance_sheet
FMP · api · 2026-09-29
https://financialmodelingprep.com/api/v3/balance-sheet-statement/FFH.TO?period=annual&limit=3
[45] Recompute DCF while varying discount_rate
Bull Run Valuation · calculation · 2026-09-29
valuation://valuation_sensitivity_table
Calcul : Recompute DCF while varying discount_rate — {"discount_rate": 0.15, "discount_rate_justification": "Uses the investor’s 15% minimum required return. Despite low structural moat and some earnings-quality volatility, Fairfax’s conservative leverage, strong recent underwriting and shareholder-friendly buybacks keep risk from demanding a materially higher hurdle in the base case.", "historical_years": [{"calendar_year": "2023", "fcf_margin": -0.021450845804591976, "revenue": 25803100000, "shares_outstanding": 25006116}, {"calendar_year": "2024", "fcf_margin": 0.1260400239076336, "revenue": 28445500000, "shares_outstanding": 22373092}, {"calendar_year": "2025", "fcf_margin": 0.0788207478973387, "revenue": 30405400000, "shares_outstanding": 21450000}], "net_debt": 3151100000, "net_debt_justification": "Uses FY2025 net debt from balance sheet (total debt minus cash) as the shared capital structure anchor.", "period": "As of 2025-12-31", "projected_years": [{"calendar_year": "2026", "fcf_margin": 0.04, "fcf_margin_justification": "Assumes partial normalization from the low TTM FCF margin (~2.8%) as working-capital swings mean-revert, but still below FY2025’s ~7.9% to avoid extrapolating peak conditions.", "revenue": 34000000000, "revenue_justification": "Reflects the run-rate implied by the 2026-Q2 TTM (~US$32.7B) plus modest organic premium growth and higher reinvestment yields, consistent with recent revenue expansion but allowing for cyclicality.", "shares_outstanding": 22050000, "shares_outstanding_justification": "~0.5% reduction vs TTM, reflecting continued buybacks but slowed from 2021–2025’s pace as valuation rises and management preserves flexibility."}, {"calendar_year": "2027", "fcf_margin": 0.05, "fcf_margin_justification": "Improves as underwriting profit stays positive and capex remains modest, with fewer adverse cash timing effects than in the TTM period.", "revenue": 36000000000, "revenue_justification": "~6% growth driven by continued premium compounding and investment income; assumes underwriting remains disciplined but market begins to normalize.", "shares_outstanding": 21900000, "shares_outstanding_justification": "~0.7% net reduction assuming steady repurchases funded by retained earnings and moderate dividends."}, {"calendar_year": "2028", "fcf_margin": 0.055, "fcf_margin_justification": "Moves toward mid-single-digit through-cycle cash generation, acknowledging that FY2024’s ~12.6% FCF margin was unusually strong.", "revenue": 38000000000, "revenue_justification": "~6% growth assumes Fairfax maintains underwriting profitability across platforms while benefiting from inflation-driven premium base.", "shares_outstanding": 21750000, "shares_outstanding_justification": "~0.7% reduction reflecting ongoing buybacks and low dilution."}, {"calendar_year": "2029", "fcf_margin": 0.055, "fcf_margin_justification": "Held steady as competitive pressures and catastrophe years offset efficiency gains; does not assume continuing reserve-release tailwinds.", "revenue": 40000000000, "revenue_justification": "~5% growth reflects gradual deceleration as the business scales; no major acquisition-driven step-change assumed.", "shares_outstanding": 21600000, "shares_outstanding_justification": "~0.7% reduction from buybacks."}, {"calendar_year": "2030", "fcf_margin": 0.057, "fcf_margin_justification": "Slight improvement from operating leverage and portfolio yield, while keeping conservatism due to investment-market cyclicality.", "revenue": 42000000000, "revenue_justification": "~5% growth assumes premiums and investment income keep compounding modestly above inflation, supported by disciplined underwriting.", "shares_outstanding": 21450000, "shares_outstanding_justification": "~0.7% reduction continuing the repurchase program."}, {"calendar_year": "2031", "fcf_margin": 0.057, "fcf_margin_justification": "Flat as steady-state assumption; recognizes that P&C underwriting profitability is not structurally expanding in a low-moat market.", "revenue": 44100000000, "revenue_justification": "~5% growth continues with exposure growth and pricing roughly in line with nominal economic growth.", "shares_outstanding": 21300000, "shares_outstanding_justification": "~0.7% reduction as long as capital returns remain a priority."}, {"calendar_year": "2032", "fcf_margin": 0.057, "fcf_margin_justification": "Flat, reflecting a stable through-cycle FCF margin slightly above the prudent case but below peak years.", "revenue": 46300000000, "revenue_justification": "~5% growth assumes sustained underwriting discipline and continued reinvestment income; no extraordinary realized gains required.", "shares_outstanding": 21150000, "shares_outstanding_justification": "~0.7% reduction from buybacks."}, {"calendar_year": "2033", "fcf_margin": 0.057, "fcf_margin_justification": "Flat to avoid embedding structural margin expansion unsupported by a strong moat.", "revenue": 48600000000, "revenue_justification": "~5% growth; assumes Fairfax maintains its diversified global platform and grows with the market.", "shares_outstanding": 21000000, "shares_outstanding_justification": "~0.7% reduction."}, {"calendar_year": "2034", "fcf_margin": 0.057, "fcf_margin_justification": "Flat stable margin, recognizing reserve releases are a judgment-driven tailwind that may not persist.", "revenue": 51000000000, "revenue_justification": "~5% growth as the company compounds book value and float; assumes no large dilution events.", "shares_outstanding": 20850000, "shares_outstanding_justification": "~0.7% reduction reflecting continued share count discipline."}, {"calendar_year": "2035", "fcf_margin": 0.057, "fcf_margin_justification": "Terminal-year margin held at ~5.7% as an earnings-power estimate under normalized conditions, well below the best historical year and above the low TTM trough.", "revenue": 53600000000, "revenue_justification": "~5% growth into the terminal period assumes Fairfax grows slightly faster than long-run inflation due to global mix and reinvestment, but not at venture-like rates.", "shares_outstanding": 20700000, "shares_outstanding_justification": "~0.7% reduction consistent with ongoing buybacks, but slower than 2021–2025’s aggressive pace."}], "terminal_growth_rate": 0.02, "terminal_growth_rate_justification": "Long-run growth set at 2% because insurance is competitive/cyclical and long-term growth should not exceed nominal GDP for extended periods; assumes Fairfax can retain and reinvest earnings but not generate perpetual above-economy growth.", "ttm": {"calendar_year": "2026-Q2", "fcf_margin": 0.02843602770061797, "revenue": 32736342741, "shares_outstanding": 22162793}, "values": [0.13, 0.14, 0.15, 0.16, 0.17], "variable": "discount_rate"}
[46] Grille interne de scoring Buffett
Bull Run Internal Scoring · internal · 2026-09-29
internal://buffett-score-grid